GE

272.05

-1.46%↓

RTX

156.35

-0.77%↓

GEV.US

650.28

-1.91%↓

HON

220.91

+0.12%↑

UNP

222.99

+0.45%↑

GE

272.05

-1.46%↓

RTX

156.35

-0.77%↓

GEV.US

650.28

-1.91%↓

HON

220.91

+0.12%↑

UNP

222.99

+0.45%↑

GE

272.05

-1.46%↓

RTX

156.35

-0.77%↓

GEV.US

650.28

-1.91%↓

HON

220.91

+0.12%↑

UNP

222.99

+0.45%↑

GE

272.05

-1.46%↓

RTX

156.35

-0.77%↓

GEV.US

650.28

-1.91%↓

HON

220.91

+0.12%↑

UNP

222.99

+0.45%↑

GE

272.05

-1.46%↓

RTX

156.35

-0.77%↓

GEV.US

650.28

-1.91%↓

HON

220.91

+0.12%↑

UNP

222.99

+0.45%↑

Search

WESCO International Inc

Slēgts

SektorsRūpniecība

207.28 -0.82

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

200.32

Max

210.66

Galvenie mērījumi

By Trading Economics

Ienākumi

-49M

118M

Pārdošana

-156M

5.3B

P/E

Sektora vidējais

16.519

42.612

EPS

2.21

Dividenžu ienesīgums

0.79

Peļņas marža

2.214

Darbinieki

20,000

EBITDA

-51M

289M

Rekomendācijas

By TipRanks

Rekomendācijas

Pirkt (spēcīgs)

Prognoze 12 mēnešiem

+9.65% upside

Dividendes

By Dow Jones

Dividenžu ienesīgums

Sektora vidējais

0.79%

2.27%

Nākamie ieņēmumi

2025. g. 30. okt.

Nākamais dividenžu datums

2025. g. 29. sept.

Nākamais Ex dividenžu datums

2025. g. 12. sept.

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

651M

11B

Iepriekšējā atvēršanas cena

208.1

Iepriekšējā slēgšanas cena

207.28

Ziņu noskaņojums

By Acuity

50%

50%

209 / 461 Rangs Industrials

Tehniskais rādītājs

By Trading Central

Pārliecība

Bearish Evidence

WESCO International Inc Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2025. g. 4. aug. 21:42 UTC

Peļņas
Iegādes, apvienošanās, pārņemšana

Cabot to Acquire Mexico Carbon Manufacturing From Bridgestone

2025. g. 4. aug. 21:21 UTC

Peļņas
Galvenie tirgus virzītāji

Vertex Stock Falls After Pain-Drug Setback, Despite Stronger 2Q Earnings -- Update

2025. g. 4. aug. 20:45 UTC

Peļņas

Vertex Pharmaceuticals Swings to 2Q Profit as Sales Climb

2025. g. 4. aug. 19:15 UTC

Galvenie tirgus virzītāji

TransMedics Group Shares Rise on FDA Approval for Clinical Trial

2025. g. 4. aug. 23:41 UTC

Tirgus saruna

Global Forex and Fixed Income Roundup: Market Talk

2025. g. 4. aug. 23:41 UTC

Tirgus saruna

Nikkei May Rise on Fed Stimulus Hopes

2025. g. 4. aug. 23:28 UTC

Tirgus saruna

Global Equities Roundup: Market Talk

2025. g. 4. aug. 23:28 UTC

Tirgus saruna

Gold Seen Stuck in Range as Investors Await Fed's Next Move -- Market Talk

2025. g. 4. aug. 21:30 UTC

Peļņas

Palantir Stock Jumps. Earnings Blew Past Wall Street's Expectations. -- Barrons.com

2025. g. 4. aug. 21:21 UTC

Peļņas
Iegādes, apvienošanās, pārņemšana

Berkshire Stock Was Hammered Monday. It's Like 1999 Again. -- Barrons.com

2025. g. 4. aug. 21:18 UTC

Peļņas

Palantir Stock Jumps. Earnings Blew Past Wall Street's Expectations. -- Barrons.com

2025. g. 4. aug. 20:25 UTC

Tirgus saruna

India Hits Back Over Russian Oil Purchases -- Market Talk

2025. g. 4. aug. 20:25 UTC

Peļņas

Transocean 2Q Loss $938M >RIG

2025. g. 4. aug. 20:25 UTC

Peļņas

Transocean 2Q Loss/Shr $1.06 >RIG

2025. g. 4. aug. 20:18 UTC

Peļņas

Palantir Stock Jumps. Earnings Blew Past Wall Street's Stratospheric Expectations. -- Barrons.com

2025. g. 4. aug. 20:15 UTC

Peļņas

Vertex Pharma: Guidance Includes Immaterial Cost Impact From Tariffs in 2025 Based on Currently Known Tariff Rates and Regulations >VRTX

2025. g. 4. aug. 20:14 UTC

Peļņas

Vertex Pharmaceuticals Reiterated FY25 Fincl Guidance >VRTX

2025. g. 4. aug. 20:14 UTC

Peļņas

Vertex Pharma: Mark Bunnage, D.Phil., SVP of Global Research, to Assume Role of CSO Effective Feb 1, 2026 >VRTX

2025. g. 4. aug. 20:14 UTC

Peļņas

Vertex Pharma: David Altshuler, Chief Scientific Officer, Intends to Retire Aug 1, 2026 >VRTX

2025. g. 4. aug. 20:13 UTC

Peļņas

Vertex Pharmaceuticals Backs FY25 Rev $11.85B-$12B >VRTX

2025. g. 4. aug. 20:09 UTC

Peļņas

Viper Energy: Initiating Avg Daily Production Guidance for 3Q of 46,000 to 49,000 Bo/d (86,000 to 92,000 Boe/d) >VNOM

2025. g. 4. aug. 20:06 UTC

Peļņas

Palantir Earnings Blow Past Wall Street's Stratospheric Expectations -- Barrons.com

2025. g. 4. aug. 20:01 UTC

Peļņas

Vertex Pharmaceuticals 2Q Net $1.03B >VRTX

2025. g. 4. aug. 20:01 UTC

Peļņas

Vertex Pharmaceuticals 2Q Adj EPS $4.52 >VRTX

2025. g. 4. aug. 20:01 UTC

Peļņas

Vertex Pharmaceuticals 2Q Rev $2.96B >VRTX

2025. g. 4. aug. 20:01 UTC

Peļņas

Vertex Pharmaceuticals 2Q EPS $3.99 >VRTX

2025. g. 4. aug. 19:41 UTC

Tirgus saruna

U.S. Natural Gas Futures Settle Lower -- Market Talk

2025. g. 4. aug. 19:28 UTC

Tirgus saruna

U.S. Hiring Expected to Recover Once Uncertainty Dissipates -- Market Talk

2025. g. 4. aug. 19:07 UTC

Tirgus saruna

Oil Extends Losing Streak As OPEC+ to Raise Output -- Market Talk

2025. g. 4. aug. 18:27 UTC

Tirgus saruna

Gold Climbs on Rate Cut Speculation -- Market Talk

Salīdzinājums

Cenas izmaiņa

WESCO International Inc Prognoze

Cenas mērķis

By TipRanks

9.65% augšup

Prognoze 12 mēnešiem

Vidējais 223.13 USD  9.65%

Augstākais 240 USD

Zemākais 200 USD

Pamatojoties uz 8 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi WESCO International Inc — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt (spēcīgs)

8 ratings

6

Pirkt

2

Turēt

0

Pārdot

Tehniskais rādītājs

By Trading Central

161.77 / 162.995Atbalsts un pretestība

Īstermiņā

Bearish Evidence

Vidējā termiņā

Weak Bullish Evidence

Ilgtermiņā

Bearish Evidence

Noskaņojums

By Acuity

209 / 461 Rangs Rūpniecība

Ziņu noskaņojums

Neutral

Volatilitāte

Zem vidējā

Ziņu apjoms (RCV)

Vidējais

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

$

Par WESCO International Inc

WESCO International, Inc. provides business-to-business distribution, logistics services, and supply chain solutions in the United States, Canada, and internationally. It operates through three segments: Electrical & Electronic Solutions (EES), Communications & Security Solutions (CSS), and Utility and Broadband Solutions (UBS). The EES segment supplies products and supply chain solutions, including electrical equipment and supplies, automation and connected devices, security, lighting, wire and cable, and safety, as well as maintenance, repair, and operating (MRO) products. This segment also offers contractor solutions, direct and indirect manufacturing supply chain optimization programs, lighting and renewables advisory services, and digital and automation solutions. The CSS segment operates in the network infrastructure and security markets. This segment sells products directly to end-users or through various channels, including data communications contractors, security, network, professional audio/visual, and systems integrators. It also provides safety and energy management solutions. The UBS segment offers products and services to investor-owned utilities; public power companies; and service and wireless providers, broadband operators, and contractors. This segment's products include wire and cables, transformers, transmission and distribution hardware, switches, protective devices, connectors, conduits, pole line hardware, racks, cabinets, safety and MRO products, and point-to-point wireless devices. This segment also offers various service solutions, including fiber project management, high and medium voltage project design and support, pre-wired meters and capacitor banks, meter testing and metering infrastructure installation, personal protective equipment dielectric testing, and tool repair, as well as emergency response, storage yard, materials, and logistics management. The company was founded in 1922 and is headquartered in Pittsburgh, Pennsylvania.